Q1 2026 earnings call recap: record $17.8M revenue, Focal One HIFU growth, guidance reiterated, risks (tariffs/cash).

The CLI 2026 User Group Conference will bring together carriers, technology experts, and industry leaders for sessions ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

MEDIA — The Delaware County Transportation Management Association has promoted Lauren Amway Fink to executive director following the retirement of Tracy Barusevicius, who led the organization since ...

Please provide your email address to receive an email when new articles are posted on . The Apollo TMS device was previously FDA cleared for treating MDD in adults. TMS offers a non-pharmacologic ...

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition affecting 1 in 36 children, with boys being diagnosed five times more often than girls. As with attention deficit/hyperactivity ...

Medicare only covers transcranial magnetic stimulation (TMS) therapy for the treatment of severe major depressive disorder (MDD). Medicare covers daily outpatient TMS therapy for up to 6 weeks when ...

Transcranial magnetic stimulation (TMS) is a noninvasive therapy that uses electromagnetic pulses to stimulate nerve cells in the brain, which can help prevent or reduce the severity and frequency of ...

Amazon Supply Chain Services launch signals major shift for freight transportation and logistics The recent announcement by Seattle-based global e-commerce giant Amazon regarding the official opening ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

Transcranial magnetic stimulation, or "TMS," is an FDA-approved psychiatric treatment for major depressive disorder and obsessive-compulsive disorder (OCD), with intriguing clinical trials suggesting ...